HKG:2407

2 stories mentioning HKG:2407Updated 15d ago

Every FINWIRES story that references HKG:2407, newest first.

Gaush Meditech Expects to Post Lower H1 Profit; Shares Plummet 7%

Gaush Meditech (HKG:2407) expects to report a net profit of 13.9 million yuan to 16.7 million yuan for the first half of 2026, down 53.5% to 61.3% from 35.9 million yuan a year earlier.The company attributed the expected decline to lower revenue amid shifts in market demand driven by national policies, the termination of its agency partnership for overseas femtosecond laser-assisted cataract surgery products, and exchange rate fluctuations, according to a Thursday Hong Kong bourse filing.Shares of the company fell over 7% in recent trade.

HKG:2407

Asia117d ago

Gaush Meditech Unit Secures EU Certification for Corneal Confocal Microscope; Shares Jump 3%

Gaush Meditech (HKG:2407) said its subsidiary Gaush Neotech obtained CE registration in the European Union for a corneal confocal microscope, according to an April 10 Hong Kong bourse filing.Shares of the ophthalmic device manufacturer were up nearly 3% in Monday's late morning trade.The CE mark allows the product to be marketed in the European Union.

HKG:2407

Track with the FINWIRES app suite

FolioX

Track HKG:2407 in your portfolio

WheelAI

Analyze HKG:2407 options with the wheel strategy

StockInsider

See market sentiment on HKG:2407